Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology

Card Electrophysiol Clin. 2016 Jun;8(2):275-84. doi: 10.1016/j.ccep.2016.01.002. Epub 2016 Mar 18.

Abstract

Human cardiomyocytes express 3 distinct types of delayed rectifier potassium channels. Human ether-a-go-go-related gene (hERG) channels conduct the rapidly activating current IKr; KCNQ1/KCNE1 channels conduct the slowly activating current IKs; and Kv1.5 channels conduct an ultrarapid activating current IKur. Here the authors provide a general overview of the mechanistic and structural basis of ion selectivity, gating, and pharmacology of the 3 types of cardiac delayed rectifier potassium ion channels. Most blockers bind to S6 residues that line the central cavity of the channel, whereas activators interact with the channel at 4 symmetric binding sites outside the cavity.

Keywords: Gating; KCNA5; KCNE1; KCNQ1; Pharmacology; Potassium channel; hERG.

Publication types

  • Review

MeSH terms

  • Delayed Rectifier Potassium Channels* / chemistry
  • Delayed Rectifier Potassium Channels* / drug effects
  • Delayed Rectifier Potassium Channels* / genetics
  • Delayed Rectifier Potassium Channels* / metabolism
  • Humans
  • Models, Molecular
  • Mutation
  • Potassium Channel Blockers* / chemistry
  • Potassium Channel Blockers* / metabolism
  • Potassium Channel Blockers* / pharmacology

Substances

  • Delayed Rectifier Potassium Channels
  • Potassium Channel Blockers